Alexion Receives NASDAQ Notification Related to the Late Filing of Form 10-Q

Alexion Receives NASDAQ Notification Related to the Late Filing of Form 10-Q


Alexion Pharmaceuticals, Inc. today announced that it received a notification letter on November 15, 2016 from The NASDAQ Stock Market . The notification letter stated that because the Company has not yet filed its Quarterly Report on Form 10-Q for the quarter ended September 30, 2016 , the Company is no longer in compliance with NASDAQ Marketplace Rule 5250 , which requires timely filing of periodic reports with the Securities and Exchange Commission .



from Biotech News